Connect with us

Health

Parvovirus or ‘slapped cheek disease’ is on the rise, CDC warns: Here’s what to know

Published

on

Parvovirus or ‘slapped cheek disease’ is on the rise, CDC warns: Here’s what to know

Join Fox News for access to this content

Plus special access to select articles and other premium content with your account – free of charge.

By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

Please enter a valid email address.

Having trouble? Click here.

A respiratory disease known as parvovirus B19 is on the rise in the U.S. among all age groups, according to a recent advisory from the U.S. Centers for Disease Control and Prevention (CDC).

The CDC issued the health alert on Aug. 13 after European public health authorities reported “unusually” high numbers of cases in 14 countries during the first quarter of 2024, the advisory said.

Advertisement

The virus typically causes a blotchy rash on the cheeks that appears as if someone has slapped them — hence its nickname, “slapped cheek disease.”

WITH MPOX A PUBLIC HEALTH EMERGENCY IN AFRICA, WHAT YOU MUST KNOW ABOUT INCREASED VIRUS RISK

“Parvovirus can be a very mild infection in many people, but if you are pregnant or are immunocompromised in any way, you are at a much greater risk of serious illness,” Dr. Aaron Glatt, chief of infectious diseases at Mount Sinai South Nassau Hospital on Long Island, New York, told Fox News Digital.

What is parvovirus B19?

Parvovirus B19 is a virus that can be easily spread by respiratory droplets in the air after an infected person coughs or sneezes, according to the CDC. 

A respiratory disease known as parvovirus B19 is on the rise in the U.S. among all age groups, according to a recent advisory from the U.S. Centers for Disease Control and Prevention (CDC). (iStock)

Advertisement

Children are often infected at school and spread it to other kids through close personal contact, then later to adults when they come home, experts say.

Approximately 50% of people who were not previously infected contract the virus from an infected family member — while 20% to 50% of susceptible students and staff become infected during school outbreaks, the advisory notes.

“The virus is highly contagious and can spread asymptomatically,” Dr. Marc Siegel, senior medical analyst for Fox News and clinical professor of medicine at NYU Langone Medical Center, told Fox News Digital.

WEST NILE DEATH REPORTED IN TEXAS AS HEALTH OFFICIALS WARN RESIDENTS TO SAFEGUARD AGAINST MOSQUITOES

Parvovirus B12 is also known as “fifth disease” because it was previously listed fifth on a list of common childhood viral illnesses that cause rashes, according to Mayo Clinic.

Advertisement

(The top three on this list are measles, rubella and scarlet fever.)

Symptoms of the virus

Many people who get infected don’t have symptoms, but some will experience sickness, according to the advisory.

About a week after an exposure, susceptible children may complain of flu-like symptoms, including fever, muscle pain and fatigue, which generally last less than a week.

People are most contagious in this early phase of the illness.

The virus typically causes a blotchy rash on the cheeks that appears as if someone has slapped them — hence the nickname “slapped cheek disease.” (iStock)

Advertisement

Several days after the fever starts, children often develop the hallmark blotchy “slapped cheek” rash — a helpful clue that health care providers use to diagnose the illness. 

People are generally not infectious by the time they develop the rash, experts say.

A fine, “lacy” rash may follow on the chest, back, buttocks, or arms and legs that is sometimes itchy, according to the CDC. It usually goes away in about a week to 10 days.

WEST NILE DEATH REPORTED IN TEXAS AS HEALTH OFFICIALS WARN RESIDENTS TO SAFEGUARD AGAINST MOSQUITOES

Adults are less likely to develop the “slapped cheek” rash. Their most common symptoms are a generalized rash on the body and joint pain that affects the hands, feet and knees.

Advertisement

In some cases, adults only experience joint pain, which usually lasts one to three weeks – although it can last for months. It usually resolves without long-term complications.

Antibodies provide immunity

Antibodies from prior infection help prevent recurrence of parvovirus B12, the CDC said.

“Once infected, you have a lifetime immunity,” Siegel noted.

The largest increase in infections was among children ages 5 to 9. 

Most adults in the United States are immune — with 50% having detectable antibody levels by age 20, and more than 70% acquiring them by age 40, per the advisory.

Advertisement

LISTERIA INFECTION LINKED TO DELI MEATS KILLS 2, INFECTS 28 ACROSS US, CDC WARNS

The share of people who have had a recent infection dropped below 3% between 2022 and 2024, but increased to 10% in June of this year.

The largest increase in infections was among children ages 5 to 9, going from 15% to 40% in that time frame, the health alert noted.

People who work in settings with close contact with children, such as schools and day cares, are at a greater risk of infection.

High-risk populations

Most healthy adults and children only have a mild illness, but people with weakened immune systems, pregnant women and those with chronic blood disorders can develop serious health complications from this virus, according to the CDC.

Advertisement

“Anyone with those conditions should be very quick to seek out medical attention to help address potential complications,” Glatt noted.

Pregnant women who are susceptible to the virus may spread the illness to their babies, the CDC warned. (iStock)

Pregnant women who are susceptible to the virus may spread the illness to their babies, the CDC warned.

“Unfortunately, there is an increased risk of miscarriage if you get parvovirus during pregnancy,” Glatt said.

      

Advertisement

Parvovirus infection may lead to adverse outcomes — such as severe anemia in the fetus and miscarriage — in 5% to 10% of cases during pregnancy, with the highest risk at between 9 and 20 weeks of fetal gestation, per the advisory.

While parvovirus B19 can affect humans of all ages, only two out of 10 individuals will have physical symptoms. (iStock)

“There is an increased risk of complications in patients with significant immunocompromising conditions, such as those who have leukemia, have received an organ transplant or have an HIV infection,” Glatt added.

Since most adults are immune to the virus, however, many pregnant women are protected from the virus, the CDC noted.

Treatment is mainly ‘supportive care’

Infected pregnant women primarily receive supportive care, which means treating the underlying symptoms and monitoring for severe fetal anemia, according to the advisory.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

People with weakened immune systems or those with chronic blood disorders can sometimes develop bone marrow failure as a result of the virus, the advisory added. 

In that case, treatment often includes blood cell transfusions and intravenous immunoglobulin (IVIG).

People are generally not infectious by the time they develop the rash, experts say. (iStock)

(IVIG is a collection of antibodies that strengthens the immune system, according to Mayo Clinic’s website.)

Advertisement

There is currently no vaccine to prevent parvovirus B19, and most people infected with the virus will recover without any long-term complications.

For more Health articles, visit www.foxnews.com/health

“While there is no specific treatment for parvovirus infection, recognizing the complications and addressing them early may be of benefit,” Glatt added.

Hand-washing can also help to prevent transmission, according to Siegel.

Advertisement

Health

176 Lbs—Gone! Why One Woman’s Gentle Weight-Loss Tips Really Work

Published

on

176 Lbs—Gone! Why One Woman’s Gentle Weight-Loss Tips Really Work


Advertisement




Cheri’s Gentle Weight-Loss Approach Helped Her Lose Big | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Brain aging may accelerate after cancer treatment, study suggests

Published

on

Brain aging may accelerate after cancer treatment, study suggests

NEWYou can now listen to Fox News articles!

Surviving cancer as a child or young adult may have a lasting impact on aging, new research suggests.

Researchers at the University of Rochester Medical Center looked at whether life-saving treatments, like chemotherapy and radiation, could speed up biological aging.

They also aimed to determine whether this age acceleration was linked to cognitive issues related to memory, focus and learning.

The team analyzed blood samples from a group of 1,400 long-term survivors treated at St. Jude Children’s Research Hospital, using epigenetic clocks — tools that estimate biological age by examining chemical tags on DNA.

Advertisement

Biological age is determined based on damage the cells accumulate over time, versus chronological age, which is measured by how long someone has been alive, according to scientists.

Biological age is determined based on the damage cells accumulate over time, according to scientists. (iStock)

“These well-established aging-related biomarkers have previously been associated with neurocognitive impairment and decline in older non-cancer populations, particularly in cognitive domains related to aging and dementia, such as memory, attention and executive function,” the study stated.

Most of the group consisted of acute lymphoblastic leukemia survivors, or Hodgkin lymphoma survivors. Participants were at least five years past their treatment, though some had survived for several decades.

They underwent neurocognitive testing to measure their attention span, memory and information processing speed.

Advertisement

CREATIVE HOBBIES KEEP THE BRAIN YOUNG, STUDY FINDS — HERE ARE THE BEST ONES TO PURSUE

Chemotherapy was found to have the greatest impact on aging acceleration. The study suggests the treatment can alter DNA structure and cause cellular damage.

CLICK HERE FOR MORE HEALTH STORIES

“It’s no surprise to find out that young people with cancer who have chemo early in life are affected in terms of long-term aging,” Dr. Marc Siegel, senior medical analyst for Fox News, told Fox News Digital.

Participants underwent neurocognitive testing to measure their attention span, memory and speed of information processing. (iStock)

Advertisement

Researchers also found that cellular aging was closely linked to cognitive performance, as survivors of a higher biological age had more difficulty with memory and attention.

“Chemo poisons and damages cellular function — hopefully the cancer cells more than normal cells, but there is a significant impact on normal cells as well,” said Siegel, who was not involved in the study.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“There is also something called ‘chemo brain,’ which causes at least temporary difficulty with memory, concentration, word finding and brain fog,” the doctor added.

The research team hopes to use these findings to focus on intervention efforts, specifically by determining when accelerated aging begins.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Young cancer survivors have many more decades of life to live,” lead study author AnnaLynn Williams, PhD, said in a press release. “If these accelerated aging changes are occurring early on and setting them on a different trajectory, the goal is to intervene to not only increase their lifespan, but improve their quality of life.”

The team hopes this research will help in the development of early intervention tools that aim to prevent cognitive decline. (iStock)

There were some limitations to the study. The researchers could not adjust for chronic health conditions or education because they are directly impacted by treatment.

Additionally, the study only looked at the survivors at a single point of time, so it could not directly prove causation.

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The study was published in the journal Nature Communications.

Fox News Digital reached out to the researchers for comment.

Related Article

4 anti-aging approaches revealed in 2025 that may help Americans live longer
Continue Reading

Health

GLP-1 Drugs Linked to Osteoporosis and Gout: Here’s How To Stay Safe

Published

on

GLP-1 Drugs Linked to Osteoporosis and Gout: Here’s How To Stay Safe


Advertisement




GLP-1 Drugs Linked To Increased Risk of Osteoporosis and Gout | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading
Advertisement

Trending